CTRI/2013/07/003793已完成3 期
Comparative Evaluation of Safety and Efficacy of Hydrochlorothiazide CR with Hydrochlorothiazide and Chlorthalidone in patients with Stage I Essential Hypertension
Ipca Laboratories Ltd Mumbai0 个研究点目标入组 54 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i)patients with Systolic Blood Pressure-140-159mmHg and Diastolic Blood Pressure-90-99mmHg
排除标准
- •i)patients with secondary hypertension
- •ii) Patients with significant cardiovascular disease
- •iii)Patients with abnormal renal, liver function
- •iv)Patients currently uncontrolled on thiazide type diuretics
- •v)patients who have used another investigational agent/device within last 30 days prior to enrollment
- •vi) Patients taking concomitant medications known to alter the blood pressure or to affect the action of study drug
- •vii) Patients with known history of hypersensitivity to study drugs or other drugs of same chemical class
- •viii) Pregnant or lactating women or women of child-bearing potential not practicing contraception
研究者
相似试验
招募中
不适用
Hominax for improving sperm healthSperm healthAlternative and complementary medicineReproductive Health and Childbirth - Fertility including in vitro fertilisationAlternative and Complementary Medicine - Other alternative and complementary medicineACTRN12616000194460Max Biocare Pty Ltd62
已完成
不适用
To determine the safety and effectiveness of Hair Fall Control Oil Shots in hair fall reduction in Healthy Adult Human Subjects with Hair FallCTRI/2022/04/041710Brillare Science Private Limited16
已完成
不适用
To check the Safety and Effectiveness of Hair Fall Control Shampoo in Healthy Adult Human Subjects with Hair Fall ComplaintsCTRI/2022/08/044868Vasu Healthcare Private Limited Vasu Research Centre32
已完成
不适用
To assess the Safety and Effectiveness of Hair Growth Promoting Product in Healthy Adult Human Subjects with Hair Fall ComplaintsCTRI/2022/11/047330Anveya Living Private Limited29
招募中
Unknown
Randomized comparison of efficacy and safety of high-intensity rosuvastatin/ezetimibe combination versus treat-to-target rosuvastatin monotherapy for patients with peripheral artery or polyvascular diseaseDiseases of the circulatory systemKCT0009107Yonsei University Health System, Severance Hospital2,462